Prevalence of human papillomavirus antibodies in young female subjects in England

Mostrar otras versiones (1)

Sera from 1483 female subjects in England aged 10–29 years were tested. The age-standardised seroprevalence was 10.7% (95% confidence intervals 9.0–12.3) for human papillomavirus (HPV) 6, 2.7% (1.8–3.6) for HPV 11, 11.9% (10.2–13.6) for HPV 16, 4.7% (3.5–5.8) for HPV 18, and 20.7% (18.6–22.7) for an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jit, M, Vyse, A, Borrow, R, Pebody, R, Soldan, K, Miller, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360425/
https://www.ncbi.nlm.nih.gov/pubmed/17726462
http://dx.doi.org/10.1038/sj.bjc.6603955
_version_ 1782153046122299392
author Jit, M
Vyse, A
Borrow, R
Pebody, R
Soldan, K
Miller, E
author_facet Jit, M
Vyse, A
Borrow, R
Pebody, R
Soldan, K
Miller, E
author_sort Jit, M
collection PubMed
description Sera from 1483 female subjects in England aged 10–29 years were tested. The age-standardised seroprevalence was 10.7% (95% confidence intervals 9.0–12.3) for human papillomavirus (HPV) 6, 2.7% (1.8–3.6) for HPV 11, 11.9% (10.2–13.6) for HPV 16, 4.7% (3.5–5.8) for HPV 18, and 20.7% (18.6–22.7) for any of the four types.
format Text
id pubmed-2360425
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23604252009-09-10 Prevalence of human papillomavirus antibodies in young female subjects in England Jit, M Vyse, A Borrow, R Pebody, R Soldan, K Miller, E Br J Cancer Short Communication Sera from 1483 female subjects in England aged 10–29 years were tested. The age-standardised seroprevalence was 10.7% (95% confidence intervals 9.0–12.3) for human papillomavirus (HPV) 6, 2.7% (1.8–3.6) for HPV 11, 11.9% (10.2–13.6) for HPV 16, 4.7% (3.5–5.8) for HPV 18, and 20.7% (18.6–22.7) for any of the four types. Nature Publishing Group 2007-10-08 2007-08-28 /pmc/articles/PMC2360425/ /pubmed/17726462 http://dx.doi.org/10.1038/sj.bjc.6603955 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
Jit, M
Vyse, A
Borrow, R
Pebody, R
Soldan, K
Miller, E
Prevalence of human papillomavirus antibodies in young female subjects in England
title Prevalence of human papillomavirus antibodies in young female subjects in England
title_full Prevalence of human papillomavirus antibodies in young female subjects in England
title_fullStr Prevalence of human papillomavirus antibodies in young female subjects in England
title_full_unstemmed Prevalence of human papillomavirus antibodies in young female subjects in England
title_short Prevalence of human papillomavirus antibodies in young female subjects in England
title_sort prevalence of human papillomavirus antibodies in young female subjects in england
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360425/
https://www.ncbi.nlm.nih.gov/pubmed/17726462
http://dx.doi.org/10.1038/sj.bjc.6603955
work_keys_str_mv AT jitm prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland
AT vysea prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland
AT borrowr prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland
AT pebodyr prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland
AT soldank prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland
AT millere prevalenceofhumanpapillomavirusantibodiesinyoungfemalesubjectsinengland

Ejemplares similares